Effects of Interventions on Cerebral Perfusion in the Alzheimer's Disease Spectrum: A Systematic Review

OnderzoeksoutputAcademicpeer review

1 Citaat (Scopus)
20 Downloads (Pure)


Cerebral perfusion dysfunctions are seen in the early stages of Alzheimer's disease (AD). We systematically reviewed the literature to investigate the effect of pharmacological and non-pharmacological interventions on cerebral hemodynamics in randomized controlled trials involving AD patients or Mild Cognitive Impairment (MCI) due to AD. Studies involving other dementia types were excluded. Data was searched in April 2021 on MEDLINE, Embase, and Web of Science. Risk of bias was assessed using Cochrane Risk of Bias Tool. A meta-synthesis was performed separating results from MCI and AD studies. 31 studies were included and involved 310 MCI and 792 AD patients. The MCI studies (n=8) included physical, cognitive, dietary, and pharmacological interventions. The AD studies (n=23) included pharmacological, physical interventions, and phytotherapy. Cerebral perfusion was assessed with PET, ASL, Doppler, fNIRS, DSC-MRI, Xe-CT, and SPECT. Randomization and allocation concealment methods and subject characteristics such as AD-onset, education, and ethnicity were missing in several papers. Positive effects on hemodynamics were seen in 75% of the MCI studies, and 52% of the AD studies. Inserting cerebral perfusion outcome measures, together with established AD biomarkers, is fundamental to target all disease mechanisms and understand the role of cerebral perfusion in AD.

Originele taal-2English
Aantal pagina's22
TijdschriftAgeing Research Reviews
Vroegere onlinedatum4-jun-2022
StatusPublished - aug-2022

Citeer dit